CONOLIDINE - AN OVERVIEW

These final results, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the thought of concentrating on ACKR3 as a unique solution to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders.Long-term suffering is complex, and